MedTech Global Insights

What's next in the future of health? Welcome to MedTech Global Insights, the podcast dedicated to uncovering the most disruptive technologies and brilliant minds in the medical field. Whether you're an industry professional, investor, or simply curious, subscribe for your dose of cutting-edge information and expert commentary.

MedTech Global Insights is a science podcast hosted by Ran Chen, with 252 episodes on record and a Required Pod Score of 85. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Ran Chen hosts MedTech Global Insights, a science show with 252 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  MedTech Global Insights

  Pure Global: US AI MedTech Rules & The Global Fallout.

  May 7, 20262 minS0

  Last week, the US FDA released a bombshell draft guidance for AI/ML-enabled medical devices. This isn't just another update; it's a fundamental shift towards a total lifecycle regulatory model. This new framework, centered on Predetermined Change Control Plans, creates immense challenges but also opportunities for agile innovation. We break down what this means for manufacturers, from startups to global enterprises. We also explore the inevitable ripple effect this US policy will have on regulatory bodies worldwide, from the EU to Asia. Case Study: Imagine a startup with a groundbreaking cancer detection algorithm. They secured initial clearance, but now face...

  ListenShow Notes
• 

  MedTech Global Insights

  Pure Global: USA's LDT Overhaul - Navigating the FDA's New IVD Era

  May 6, 20262 minS0

  The U.S. FDA has just sent shockwaves through the diagnostics industry with a final rule to regulate Laboratory Developed Tests (LDTs) as medical devices. This decision eliminates decades of regulatory ambiguity and forces thousands of clinical laboratories into a new world of compliance, including premarket approval and quality system requirements. This episode of MedTech Global Insights breaks down the four-year transition plan, what it means for labs, and the potential impact on patient care and innovation. We explore a critical pain point: a university lab has developed a groundbreaking cancer biomarker test. Previously, they could use it for patient...

  ListenShow Notes
• 

  MedTech Global Insights

  USA MedTech M&A: Pure Global on The Deal Frenzy of 2026.

  May 5, 20262 minS0

  The start of 2026 has been marked by a huge wave of multi-billion dollar mergers and acquisitions in the MedTech industry. Giants like Abbott and Boston Scientific are spending big to acquire innovators in diagnostics and neurovascular tech, fundamentally reshaping the competitive landscape. This activity signals a major strategic shift towards portfolio optimization and acquiring innovation rather than building it. This episode of MedTech Global Insights analyzes the strategy behind this M&A frenzy. We dissect what these mega-deals mean for the future of the industry and explore the immense pressure it puts on small and mid-sized companies who now must...

  ListenShow Notes
• 

  MedTech Global Insights

  Pure Global: US Cyber Rules & The MedTech Rejection Wave

  May 4, 20262 minS0

  The FDA has drawn a new line in the sand for medical device cybersecurity. Since March 2024, the "Refuse to Accept" policy is in full effect, turning premarket submissions into a high-risk gamble for unprepared manufacturers. In this episode, we dissect the immediate fallout and what companies are experiencing right now. We explore how a missing Software Bill of Materials (SBOM) or a weak post-market surveillance plan can halt your U.S. market access indefinitely. Imagine spending millions to develop a groundbreaking connected device, only to have the FDA reject your submission based on a cybersecurity technicality. Your launch is delayed...

  ListenShow Notes
• 

  MedTech Global Insights

  EU's AI-MDR Maze: Pure Global on Dual Regulation Traps

  May 3, 20262 minS0

  The European Commission has just released critical new guidance on how the EU AI Act and the Medical Device Regulation (MDR) will work together. This creates a new reality of dual regulation for MedTech innovators, fundamentally changing the requirements for placing and maintaining AI-driven medical devices on the European market. This episode breaks down what this new intersection means for manufacturers, the immediate compliance gaps you need to address, and the long-term strategic implications for the global MedTech landscape. Imagine your AI diagnostic software, already CE-marked and on the market, is suddenly flagged for non-compliance during an audit because its...

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.